FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages

被引:41
|
作者
Yang, Jing-Bo [1 ,2 ]
Zhao, Zhi-Bin [1 ,2 ,3 ,4 ]
Liu, Qing-Zhi [1 ,2 ,3 ,4 ]
Hu, Tai-Dou [1 ,2 ,3 ,4 ]
Long, Jie [1 ,2 ,3 ,4 ]
Yan, Kai [1 ,2 ,3 ,4 ]
Lian, Zhe-Xiong [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Liver Immunol Lab, Hefei, Anhui, Peoples R China
[2] Univ Sci & Technol China, Med Ctr, Hefei, Anhui, Peoples R China
[3] South China Univ Technol, Inst Life Sci, Chron Dis Lab, Guangzhou, Guangdong, Peoples R China
[4] South China Univ Technol, Sch Med, Guangzhou, Guangdong, Peoples R China
[5] Hefei Natl Lab Phys Sci Microscale, Innovat Ctr Cell Signaling Network, Hefei, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
DENDRITIC CELLS; MYELOID CELLS; IN-VIVO; PROGRESSION; CANCER; POLARIZATION; METASTASIS; HYPOXIA; MICE; INVASION;
D O I
10.1038/s41388-017-0048-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages are a critical component in host immune responses against tumor. In this work we investigated the role of forkhead box O1 (FoxO1) in the transcriptional regulation in macrophages, which affects the anti-tumor functions of tumor-associated macrophages (TAMs). First, we showed that TAMs expressed reduced levels of FoxO1, which was associated with their protumoral M2 polarization state. The suppression of FoxO1 expression in TAM was induced by the hypoxic condition in the tumor microenviroment. Next, we confirmed that FoxO1 positively regulates MHC-II genes by binding to the promoter region of Ciita gene, the master activator of multiple MHC-II genes. Loss of FoxO1 in TAMs resulted in reduced MHC-II expression. Furthermore, we used FoxO1 conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth. These results demonstrate that the protumoral property of TAMs is induced by the hypoxia-triggered FoxO1 deficiency, which could be a potential target of novel anti-tumor therapies.
引用
收藏
页码:1192 / 1204
页数:13
相关论文
共 50 条
  • [41] Tumor Associated Macrophages and TAMs-Based Anti-Tumor Nanomedicines
    Cheng, Yuxi
    Song, Siyang
    Wu, Peiyao
    Lyu, Bochen
    Qin, Mengmeng
    Sun, Yanan
    Sun, Aning
    Mu, Limin
    Xu, Fei
    Zhang, Lu
    Wang, Jiancheng
    Zhang, Qiang
    [J]. ADVANCED HEALTHCARE MATERIALS, 2021, 10 (18)
  • [42] THE EFFECT OF LIPOPROTEIN ON THE ANTI-TUMOR ACTIVITY OF MACROPHAGES
    JUSTEMENT, LB
    ZWILLING, BS
    [J]. FEDERATION PROCEEDINGS, 1983, 42 (04) : 955 - 955
  • [43] Characterization of TAMP1 expression and function in tumor-associated macrophages
    Dollt, C.
    Michel, J.
    Schoenhaar, K. L.
    Schledzewski, K.
    Goerdt, S.
    Schmieder, A.
    [J]. EXPERIMENTAL DERMATOLOGY, 2014, 23 (03) : E45 - E45
  • [44] High Expression of CSF-1R Predicts Poor Prognosis and CSF-1Rhigh Tumor-Associated Macrophages Inhibit Anti-Tumor Immunity in Colon Adenocarcinoma
    Wang, Xingchao
    Zhang, Jianfeng
    Hu, Baoying
    Qian, Fei
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Integrin agonists reduce infiltration of tumor-associated macrophages to promote T-cell mediated anti-tumor immunity
    Khan, Samia Q.
    Faridi, Mohd. H.
    Khaliqdina, Shehryar J.
    Barbosa, Antonio J.
    Varner, Judith A.
    Gupta, Vineet
    [J]. CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [46] USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer
    Dai, Xiaomeng
    Lu, Lisen
    Deng, Suke
    Meng, Jingshu
    Wan, Chao
    Huang, Jing
    Sun, Yajie
    Hu, Yan
    Wu, Bian
    Wu, Gang
    Lovell, Jonathan F.
    Jin, Honglin
    Yang, Kunyu
    [J]. THERANOSTICS, 2020, 10 (20): : 9332 - 9347
  • [47] Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma
    Liaw, Kevin
    Sharma, Rishi
    Sharma, Anjali
    Salazar, Sebastian
    Appiani La Rosa, Santiago
    Kannan, Rangaramanujam M.
    [J]. Journal of Controlled Release, 2021, 329 : 434 - 444
  • [48] Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma
    Liaw, Kevin
    Sharma, Rishi
    Sharma, Anjali
    Salazar, Sebastian
    La Rosa, Santiago Appiani
    Kannan, Rangaramanujam M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 329 : 434 - 444
  • [49] Anti-tumor properties of FoxO1 in YD-9 oral squamous cell carcinoma cells
    Kim, Yu Gyung
    Seong, Chaeeun
    Cho, Kyoung-Ah
    Lee, Sang Min
    Kim, Tae-Jun
    Kim, Hyeon Ji
    Cho, Jin-Hwa
    Jung, Won
    Jang, Sungil
    Shin, Jae-Cheon
    Lee, Kyung-Ha
    Byun, Jin-Seok
    Kim, Do-Yeon
    [J]. ONCOLOGY REPORTS, 2023, 49 (06)
  • [50] Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
    He, Yingying
    Liu, Tao
    Dai, Shuang
    Xu, Zihan
    Wang, Li
    Luo, Feng
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9